title: Heparan sulfate-dependent enhancement of henipavirus infection.
abstract: Nipah virus and Hendra virus are emerging, highly pathogenic, zoonotic paramyxoviruses that belong to the genus Henipavirus. They infect humans as well as numerous mammalian species. Both viruses use ephrin-B2 and -B3 as cell entry receptors, and following initial entry into an organism, they are capable of rapid spread throughout the host. We have previously reported that Nipah virus can use another attachment receptor, different from its entry receptors, to bind to nonpermissive circulating leukocytes, thereby promoting viral dissemination within the host. Here, this attachment molecule was identified as heparan sulfate for both Nipah virus and Hendra virus. Cells devoid of heparan sulfate were not able to mediate henipavirus trans-infection and showed reduced permissivity to infection. Virus pseudotyped with Nipah virus glycoproteins bound heparan sulfate and heparin but no other glycosaminoglycans in a surface plasmon resonance assay. Furthermore, heparin was able to inhibit the interaction of the viruses with the heparan sulfate and to block cell-mediated trans-infection of henipaviruses. Moreover, heparin was shown to bind to ephrin-B3 and to restrain infection of permissive cells in vitro. Consequently, treatment with heparin devoid of anticoagulant activity improved the survival of Nipah virus-infected hamsters. Altogether, these results reveal heparan sulfate as a new attachment receptor for henipaviruses and as a potential therapeutic target for the development of novel approaches against these highly lethal infections.
  
  
  OBJECTIVE
  The Henipavirus genus includes two closely related, highly pathogenic paramyxoviruses, Nipah virus and Hendra virus, which cause elevated morbidity and mortality in animals and humans. Pathogenesis of both Nipah virus and Hendra virus infection is poorly understood, and efficient antiviral treatment is still missing. Here, we identified heparan sulfate as a novel attachment receptor used by both viruses to bind host cells. We demonstrate that heparin was able to inhibit the interaction of the viruses with heparan sulfate and to block cell-mediated trans-infection of henipaviruses. Moreover, heparin also bound to the viral entry receptor and thereby restricted infection of permissive cells in vitro. Consequently, heparin treatment improved survival of Nipah virus-infected hamsters. These results uncover an important role of heparan sulfate in henipavirus infection and open novel perspectives for the development of heparan sulfate-targeting therapeutic approaches for these emerging infections.
authors.forename: Cyrille
authors.initials: C
authors.lastname: Mathieu
authors.forename: Kévin P
authors.initials: KP
authors.lastname: Dhondt
authors.forename: Marie
authors.initials: M
authors.lastname: Châlons
authors.affiliation: Laboratory P4-Jean Mérieux, INSERM, Lyon, France.
authors.forename: Stéphane
authors.initials: S
authors.lastname: Mély
authors.affiliation: Laboratory P4-Jean Mérieux, INSERM, Lyon, France.
authors.forename: Hervé
authors.initials: H
authors.lastname: Raoul
authors.forename: Didier
authors.initials: D
authors.lastname: Negre
authors.forename: François-Loïc
authors.initials: FL
authors.lastname: Cosset
authors.forename: Denis
authors.initials: D
authors.lastname: Gerlier
authors.forename: Romain R
authors.initials: RR
authors.lastname: Vivès
authors.affiliation: branka.horvat@inserm.fr.
authors.forename: Branka
authors.identifier: http://orcid.org/0000-0003-0578-7765
authors.initials: B
authors.lastname: Horvat
mesh_terms: D000818:Animals; D002478:Cells, Cultured; D006224:Cricetinae; D045404:Hendra Virus / Q000502:physiology*; D045464:Henipavirus Infections / Q000473:pathology* / Q000821:virology*; D006497:Heparan Sulfate / Q000378:metabolism*; D006801:Humans; D007962:Leukocytes / Q000821:virology; D045405:Nipah Virus / Q000502:physiology*; D020349:Surface Plasmon Resonance; D016019:Survival Analysis; D053585:Virus Attachment
chemical_list: D006497:Heparan Sulfate